The slip
PARKINSON RECEIPTno. 12904
28 Oct 2026, 10:00 UTColigodendrocytes, braak
predictionCASKIN2 in oligodendrocytes tracks Braak Lewy-body stage
registered0d26980c5e27f7b3
discovery-0.41 p=0.276 n=9
replication-0.42 p=0.262 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.41, p 0.276)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT744a865b163efe2adb049ef7…
follows 3e71a278657c…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 12904: CASKIN2 in oligodendrocytes, braak
- power
- full sample -0.48 (p 0.042, n 18), 95% CI -0.78 to -0.02. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.54 (p 0.022, n 18). holds up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.51 (p 0.031, n 18). not the mix.
- skeptic
- leave-one-out range -0.59 to -0.42, sign flips 0; without severely affected donors -0.48 (p 0.042, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CASKIN2 in oligodendrocytes.
case closed: nothing better to follow up.